Cullinan Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Cullinan Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2024.
  • Cullinan Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 58.3M shares, a 36.5% increase year-over-year.
  • Cullinan Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 41.6M shares, a 8% decline from 2022.
  • Cullinan Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 45.2M shares, a 4.85% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 58.3M +15.6M +36.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 55.1M +15.1M +37.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 43M +2.33M +5.73% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 41.6M -3.61M -8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 42.7M -2.88M -6.31% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 40M -4.92M -11% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 40.7M -3.75M -8.44% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 45.2M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 45.6M +2.17M +5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 44.9M +1.58M +3.65% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 44.4M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 43.4M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 43.3M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.